HealthEquity (HQY) Q2 2026 earnings review
Margin Recovery Powers Earnings Beat; Legislative Wins Pave Path for Future Growth
HealthEquity delivered a strong Q2, beating expectations and raising full-year guidance. The outperformance was driven by a significant recovery in margins, with Adjusted EBITDA margin hitting a near-record 46%. This was a direct result of successfully containing the fraud-related service costs that plagued prior quarters and continued growth in high-margin custodial revenue. While top-line revenue growth decelerated to 9% YoY amid a softer macro environment, the quality of earnings improved dramatically. A major new catalyst emerged as recent legislation will significantly expand HSA eligibility to millions of Americans on ACA bronze plans, creating a substantial new market for the company to target in 2026.
🐂 Bull Case
The company proved it has contained the fraud-related costs, driving gross margin to a record 71% and Adj. EBITDA margin to 46%. This demonstrates significant operating leverage and a clear path to higher profitability.
The largest HSA expansion in 20 years was passed, making all ACA bronze and catastrophic plans HSA-eligible. This opens a new addressable market of over 7 million individuals, providing a multi-year growth runway.
The company generated strong cash flow, enabling a $66M share repurchase and a $50M debt paydown in the quarter. Management is actively de-risking future revenue by hedging interest rate exposure on its cash balances.
🐻 Bear Case
YoY revenue growth has slowed for five consecutive quarters, from 23% in Q2 FY25 to 9% in Q2 FY26. This reflects tougher comps on custodial revenue and slower new account growth tied to a weaker labor market.
New HSA sales were down 13% YoY, which management directly attributed to a softer macro environment. The core account growth engine remains sensitive to job growth and employment trends.
While guidance was raised, it implies a slowdown in revenue and margins in the second half of the year due to seasonality and planned increases in technology spending, suggesting the strong Q2 pace is not sustainable through year-end.
⚖️ Verdict: 🟢
Bullish. The successful containment of fraud costs and the resulting margin recovery is a major de-risking event that confirms the company's operational execution. While top-line growth is slowing, the emergence of a significant, new legislative catalyst in the ACA market provides a clear path to re-accelerate growth in the medium term. The company is performing well on the factors within its control.
Key Themes
Fraud Cost Containment Unlocks Margin Expansion
The primary driver of the earnings beat was the successful reduction of fraud-related service costs. After incurring approximately $17M in Q4 and $3M in Q1, direct fraud costs fell to just $1.2M in Q2. Management is now on track to hit its target of reducing these costs to one basis point of total HSA assets. This operational turnaround was the key factor behind the record 71% gross margin and near-record 46% Adjusted EBITDA margin, reversing the compression seen in late FY25.
Legislative Wins Create New Multi-Million Customer Market
A newly passed budget bill delivered the largest expansion of HSA regulations in 20 years. Crucially, it makes all individual bronze and catastrophic plans on ACA exchanges HSA-eligible starting January 1, 2026. This opens a new market of over 7 million people, approximately 90% of whom were previously unable to open an HSA. The company is actively redesigning its enrollment and marketing to capture this new, direct-to-consumer segment, creating a significant long-term growth catalyst.
Top-Line Revenue Growth is Decelerating
A key point of caution is the steady deceleration in YoY revenue growth, which has fallen from 23% in Q2 FY25 to just 9% this quarter. This trend is driven by two factors: tougher year-over-year comparisons for Custodial revenue as the initial surge from interest rate hikes normalizes, and a softer macroeconomic environment that led to a 13% YoY decline in new HSAs from sales in Q2. This indicates the company is facing headwinds to its top-line growth rate.
Proactive Hedging De-Risks Future Custodial Revenue
While custodial revenue growth is slowing, management is actively protecting this income stream. The company entered into an additional $1.2 billion of treasury bond forward contracts during the quarter, locking in an average 5-year treasury rate of just over 4%. This strategy de-risks future placements and pulls forward favorable rates, providing greater visibility and stability for a key earnings driver.
AI Investments Driving Service Efficiency
The company's technology investments are yielding tangible results. Service costs declined year-over-year despite a 5% increase in total accounts, a clear sign of operating leverage. Management highlighted the success of its AI-powered 'expedited claims' and announced plans to further leverage 'AgenTik AI' in its voice channel. This focus on automation is enhancing the member experience while creating a more efficient, scalable cost structure.
Strategic Shift to 'Secure Mobile Experience' Takes Hold
In response to past fraud challenges, the company's strategy of pushing members to a secure mobile app is gaining traction. App downloads have reached 1.7 million, and the company has begun rolling out more secure 'passkey' authentication technology. This strategic shift is the core enabler of the fraud cost reduction and is central to the company's plan to modernize its service delivery.
Other KPIs
Stable. Custodial revenue remains the primary growth engine, up 15% YoY to $159.9M, driven by an annualized yield of 3.51% on HSA cash. Interchange revenue grew a healthy 8% to $48.1M, outpacing account growth and indicating strong member spending activity. Service revenue was flat at $117.9M (+1% YoY) as efficiency gains and lower fraud costs offset modest top-line pressure.
Accelerating engagement. Total HSA assets grew 12% YoY. Notably, HSA investments grew 23% to $16.1B, while HSA cash grew just 4% to $17.0B. The faster growth in investments signals deepening engagement from members who are using their accounts for long-term wealth building, not just spending.
Stable. The company continues to generate strong cash flow, enabling a balanced approach to capital allocation. In Q2, HealthEquity repurchased $66M of its shares and paid down $50M in debt. $352M remains on the current share repurchase authorization.
Guidance
Accelerating. The midpoint of $550M was raised from $540M last quarter. This reflects growing confidence in the sustainability of the margin recovery. The full-year guidance implies an EBITDA margin of ~42.3%, a significant expansion from 39.0% in FY25.
Stable. The range was raised slightly from the prior quarter. The midpoint of $1.30B implies full-year growth of 8.4%, a deceleration from the 20% growth seen in FY25. The guidance reflects management's cautious view on the macro environment while incorporating strong custodial yields.
Accelerating. The midpoint of $3.825 represents a 22.6% increase over FY25's $3.12. This bottom-line growth, well in excess of revenue growth, highlights the significant operating leverage the company is achieving through margin expansion.